Literature DB >> 11245283

Genes that regulate metastasis and angiogenesis.

C P Webb1, G F Vande Woude.   

Abstract

Genetic instability and an accumulation of genetic and epigenetic changes during tumor progression lead to an increasingly aggressive and treatment-resistant phenotype, and ultimately metastasis. In recent years it has become well established that angiogenesis, the process by which new vasculature is formed from pre-existing vessels, is an essential component to primary tumor growth and distant metastasis. A greater understanding of the complex multitude of factors involved in tumor angiogenesis and metastasis is fundamental to the development of potential therapeutics to treat malignant disease. As highlighted throughout this review, angiogenesis and metastasis share many common cellular and molecular features. We will briefly discuss the pertinent genes involved in the regulation of angiogenesis and metastasis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11245283     DOI: 10.1023/a:1006466605356

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  199 in total

Review 1.  The diversity of T-cell co-stimulation in the induction of antitumor immunity.

Authors:  J Schlom; J W Hodge
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

2.  CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration.

Authors:  L Y Bourguignon; H Zhu; L Shao; Y W Chen
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

Review 3.  Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors.

Authors:  J M Hamby; H D Showalter
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

Review 4.  The angiopoietins: Yin and Yang in angiogenesis.

Authors:  S Davis; G D Yancopoulos
Journal:  Curr Top Microbiol Immunol       Date:  1999       Impact factor: 4.291

5.  Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy.

Authors:  P Wesseling; J A van der Laak; M Link; H L Teepen; D J Ruiter
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

Review 6.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

Review 7.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

8.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

9.  Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors:  P C Brooks; R A Clark; D A Cheresh
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

10.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

Authors:  V W Li; R D Folkerth; H Watanabe; C Yu; M Rupnick; P Barnes; R M Scott; P M Black; S E Sallan; J Folkman
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

View more
  12 in total

1.  Effects of Vietnamese Sophora Root on growth, adhesion, invasion and motility of melanoma cells.

Authors:  Dongxing Zhang; Shi Liu; Mingzhu Yao; Xiong Liu; Hongtao Lai
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.

Authors:  N S Duesbery; J Resau; C P Webb; S Koochekpour; H M Koo; S H Leppla; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

3.  Magnetic resonance imaging targeting of intracranial glioma xenografts by Resovist-labeled endothelial progenitor cells.

Authors:  Shunan Wang; Jingqin Fang; Tao Zhang; Bo Wang; Jinhua Chen; Xue Li; Shaoxiang Zhang; Weiguo Zhang
Journal:  J Neurooncol       Date:  2011-04-27       Impact factor: 4.130

4.  Glioblastoma multiforme.

Authors:  Herbert B Newton
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

5.  Monocyte chemoattractant protein 1 and fractalkine play opposite roles in angiogenesis via recruitment of different macrophage subtypes.

Authors:  Lei Chen; Gao-Qin Liu; Hong-Ya Wu; Ji Jin; Xue Yin; Dan Li; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

Review 6.  Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.

Authors:  David T Denhardt; Devra Mistretta; Ann F Chambers; Shuba Krishna; Joseph F Porter; Srilatha Raghuram; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 7.  Application of proteomics in the study of tumor metastasis.

Authors:  Zhen Cai; Jen-Fu Chiu; Qing-Yu He
Journal:  Genomics Proteomics Bioinformatics       Date:  2004-08       Impact factor: 7.691

8.  Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression.

Authors:  Chien-Min Chen; Chu-Liang Lin; Hui-Ling Chiou; Shu-Ching Hsieh; Chia-Liang Lin; Chun-Wen Cheng; Chia-Hung Hung; Jen-Pi Tsai; Yi-Hsien Hsieh
Journal:  Oncotarget       Date:  2017-02-21

9.  Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.

Authors:  Jen-Pi Tsai; Pei-Ching Hsiao; Shun-Fa Yang; Shu-Ching Hsieh; Da-Tian Bau; Chu-Liang Ling; Chun-Li Pai; Yi-Hsien Hsieh
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.

Authors:  Tsung-Ho Ying; Chien-Hsing Lee; Hui-Ling Chiou; Shun-Fa Yang; Chu-Liang Lin; Chia-Hung Hung; Jen-Pi Tsai; Yi-Hsien Hsieh
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.